Dimensional Fund Advisors
TBIO

Dimensional Fund Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-56,670
Closed -$1.04M – 3427
2020
Q4 		$1.04M Sell
56,670
-20,146
-26% -$361K ﹤0.01% 2967
2020
Q3 		$1.04M Buy
76,816
+25,412
+49% +$392K ﹤0.01% 2917
2020
Q2 		$921K Sell
51,404
-2,115
-4% -$31.9K ﹤0.01% 2963
2020
Q1 		$534K Buy
+53,519
New +$438K ﹤0.01% 3039

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Dimensional Fund Advisors's TBIO Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 56,670 shares — an estimated $1.04M sold.

Dimensional Fund Advisors first reported a position in TBIO in Q1 2020 and held it in 4 quarters. The position peaked at $1.04M in Q3 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 56,670 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $1.04M.
  • Dimensional Fund Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Dimensional Fund Advisors's Translate Bio, Inc. Common Stock position peaked at $1.04M in Q3 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.